dexmedetomidine has been researched along with Diabetic Glomerulosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, FX; Liu, W; Liu, YT; Wan, ZH; Wang, XQ | 1 |
| Choi, YS; Jun, JH; Kim, SH; Oh, JE; Oh, YJ; Shin, EJ | 1 |
2 other study(ies) available for dexmedetomidine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Protective effect of dexmedetomidine against renal injury in diabetic nephropathy rats through inhibiting NF-κB pathway.
Topics: Animals; Apoptosis; Dexmedetomidine; Diabetic Nephropathies; Female; Injections, Intraperitoneal; Kidney; Male; NF-kappa B; Protective Agents; Rats; Rats, Sprague-Dawley; Streptozocin | 2020 |
Renoprotective effects of dexmedetomidine against ischemia-reperfusion injury in streptozotocin-induced diabetic rats.
Topics: Animals; Apoptosis; Cytoprotection; Dexmedetomidine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hemodynamics; Kidney; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Streptozocin | 2018 |